SEC Form 4 · accession 0001179110-15-007278
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Bowen
Officer — Chief Financial Officer
Period of report
May 5, 2015
Accepted (ET)
May 7, 2015 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF3 | May 5, 2015 | A | 18,000 | $0.00 | A | 84,859 | D | |
| Common Stock, $.01 par valueF4,F5 | May 7, 2015 | S | 1,549 | $71.0395 | D | 83,310 | D | |
| Common Stock, $.01 par valueF4,F6 | May 7, 2015 | S | 573 | $72.1364 | D | 82,737 | D | |
| Common Stock, $.01 par valueF4,F7 | May 7, 2015 | S | 250 | $73.094 | D | 82,487 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $15.92 | holding | — | — | — | Dec 22, 2009 | Dec 22, 2018 | Common Stock | 100,000 | 100,000 | D |
| Stock Option (right to buy)F1,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (right to buy)F1,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2023 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F1,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2024 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- F2These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- F3Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 14, 2014. One third of these restricted stock units vested on May 5, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain performance milestone with the remaining vesting on the first and second anniversary of the date of the grant.
- F4Sale of common stock pursuant to reporting owner's 10b5-1 plan solely for payment of withholding tax liability associated with the vesting of performance-based awards of restricted stock units.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.7400 and $71.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.9000 and $72.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.9050 and $73.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.